PCC01: Targeting and managing special patient groups - including hands-on workshop in trophectoderm biopsy
|
 |
Cath King (United Kingdom)
|
Counseling for genetic disorders |
| |
Martine De Rycke (Belgium)
|
Microarray tools for PGD: an introduction |
| |
Anne Louise Lunoe (Denmark)
|
Dealing with miscarriage |
| |
Hetty Ockhuysen (The Netherlands)
|
Supporting women during waiting periods |
| |
Helga Sol Olafsdottir (Iceland)
|
|
| |
|
|
PCC02: Treating the man with evidence based medicine
|
| |
Rafael Oliva (Spain)
|
Training tomorrows research andrologists to embrace 21st century investigative techniques: the promise of the Reprotrain network |
| |
Sophie Pison - Rousseaux (France)
|
Molecular messages in the ejaculate remain an underestimated resource for understanding male fertility |
| |
Richard Sharpe (United Kingdom)
|
Steroidogenesis in the fetal testis and its susceptibility to disruption- the latest advances |
| |
Jackson Kirkman-Brown(United Kingdom)
|
Dietary supplements- are they any help? |
| |
Herman Tournaye (Belgium)
|
Preserving fertility before puberty: what should the clinician know? |
| |
|
|
PCC03: Time-lapse monitoring in the ART lab
|
| |
Thorir Hardarson (Sweden)
|
Time-lapse monitoring – the technique; possibilities and restrictions |
| |
Kirstine Kirkegaard (Denmark)
|
Effects of culture conditions on embryo morphokinetics |
| |
Zsolt Peter Nagy (U.S.A.)
|
What have we learned from morphokinetics about early human development: a comparison with classical scoring systems |
| |
Giovanni Coticchio, Ph.D. (Italy)
|
Expanding applications of live cell microscopy to the study of oogenesis and oocyte quality |
| |
Shawn Chavez (U.S.A.)
|
The biology behind time-lapse monitoring of embryos: correlates of aneuploidy and gene expression |
| |
Sjoerd Repping (The Netherlands)
|
An evidence-based evaluation of time-lapse monitoring in clinical embryology |
| |
Charles Kingsland (United Kingdom)
|
Time-lapse monitoring of human embryos: A clinician’s perspective |
| |
|
|
PCC04: The fallopian tube and reproductive function
|
| |
Stephen G. Hillier (United Kingdom)
|
The fallopian tube as the origin of ovarian cancer |
| |
Antoine Watrelot (France)
|
Is salpingectomy useful to prevent ovarian cancer |
| |
Justin Clark (United Kingdom)
|
Fertility control: laparoscopic versus hysteroscopic tubal obstruction |
| |
|
|
PCC05: The ethics of gamete donation and information sharing
|
| |
Anneke Lucassen (United Kingdom)
|
Gamete donation and the sharing of medical information |
| |
Theo Boer (The Netherlands)
|
Is not-telling the child morally reprehensible? |
| |
Wybo J. Dondorp (The Netherlands)
|
Telling or not-telling: should counsellors be directive? |
| |
Guido Pennings (Belgium)
|
Do donors have a right to information about their offspring? |
| |
|
|
PCC06: On seeking and finding the evidence
|
| |
Clare Lewis-Jones (United Kingdom)
|
The patient perspective |
| |
Kelly Tilleman (Belgium)
|
When can we call an intervention established? |
| |
Willianne Nelen (The Netherlands)
|
Practitioners and guidelines: 10 tips for a happy marriage |
| |
Jacqueline Pieters, , MD, PhD (The Netherlands)
|
Decision making: how to balance evidence with patient preferences |
| |
Andrea Evers (The Netherlands)
|
The Placebo effect: what is the role of suggestion in pain management |
| |
Jan Kremer (The Netherlands)
|
The art of medicine: communication or manipulation? |
| |
Ana Galhardo (Portugal)
|
The Mindfulness Based Program for Infertility: evidence regarding its efficacy |
| |
Rajvi Mehta (India)
|
Yoga: Its potential role in infertility management |
| |
|
|
PCC07: Fertility-sparing surgery in malignant and benign conditions
|
| |
Stephan Gordts (Belgium)
|
Fertility-sparing surgery (FSS) in severe endometriosis and recurrent endometrioma: What is the gold standard approach? |
| |
Tin-Chiu Li (United Kingdom)
|
Preservation of the uterus and endometrium in cases with huge and multiple intramural and/or submucous fibroids |
| |
Thomas Ind (United Kingdom)
|
Low malignant potential and early stage ovarian cancer: is there a place for FSS? |
| |
Dror Meirow (Israel)
|
Ovarian chemio prophylaxis, fertility preservation against the sterilizing effects of chemotherapy and ovarian tissue cryopreservation |
| |
|
|
PCC08: ASRM exchange course: Practical applications of clinical and basic science genetics to reproductive medicine
|
| |
Joe Leigh Simpson, MD (U.S.A.)
|
Screening couples for genetic disease presenting for reproductive care. Screening for at-risk and not at-risk individuals |
| |
Marcelle Cedars (U.S.A.)
|
Genetics of premature ovarian insufficiency |
| |
Joe Leigh Simpson, MD (U.S.A.)
|
Imprinting disorders and ART |
| |
|
|
PCC09: Academic Authorship Programme - The A to Z of research: Doing a study, presenting a poster, giving a talk, writing it up
|
| |
Johannes Evers (The Netherlands)
|
Principles of study design, treatment |
| |
Madelon Van Wely (The Netherlands)
|
Principles of study design, diagnosis |
| |
Edgardo Somigliana (Italy)
|
Giving a talk |
| |
Richard Sharpe (United Kingdom)
|
Writing a study up for a scientific journal |
| |
|
|
PCC10: Middle East Fertility Society Exchange Course: Fertility preservation in women: Facts and dilemmas
|
| |
Tommaso Falcone (U.S.A.)
|
Fertility in female cancer survivors: Pathophysiology and impact on ovarian reserve |
| |
Kutluk H. Oktay (U.S.A.)
|
Mechanisms of chemotherapy induced ovarian damage: implications for future treatments |
| |
S. Samuel Kim (U.S.A.)
|
Practice guidelines for fertility preservation in cancer patients |
| |
Kutluk H. Oktay (U.S.A.)
|
Fertility preservation in young women with breast cancer |
| |
Kutluk H. Oktay (U.S.A.)
|
Age specific success of oocyte cryopreservation: How to counsel your patient |
| |
Tommaso Falcone (U.S.A.)
|
Minimally Invasive approaches to Fertility Preservation |
| |
S. Samuel Kim (U.S.A.)
|
Current dilemmas with heterotopic ovarian transplantation: fertility or futility |
| |
Johnny Awwad (Lebanon)
|
The current fertility preservation consultation model: Are we adequately informing cancer patients of their options? |
| |
|
|
PCC11: The contribution of endocrinology and early pregnancy management to the success of an ART center
|
| |
Mariette Goddijn (The Netherlands)
|
Introduction |
| |
Waljit Dhillo (United Kingdom)
|
Gut and adipose hormones and reproduction in the human |
| |
Thomas Strowitzki (Germany)
|
Immunological and endocrine aspects of implantation |
| |
Anders Nyboe Andersen (Denmark)
|
No |
| |
Cornelis Lambalk (The Netherlands)
|
The endocrinology of pregnancy |
| |
Efstratios Kolibianakis (Greece)
|
Discussion & closing of the meeting |
| |
|
|
PCC12: The current status of PGD and PGS
|
| |
Georgia Kokkali (Greece)
|
An update on embryo biopsy |
| |
Joanne Traeger-Synodinos (Greece)
|
An update of the ESHRE PGD Consortium |
| |
Joep Geraedts (The Netherlands)
|
RCT results for PGS |
| |
Laura Francesca Rienzi (Italy)
|
The biology of aneuploidy in preimplantation embryos and implications for PGD/PGS |
| |
Hubert Smeets (The Netherlands)
|
PGD in mitochondrial DNA disorders |
| |
Guido De Wert (The Netherlands)
|
Ethical dilemmas in PGD/PGS |
| |
|
|
PCC13: Of stem cells and gametes: more similarities than differences?
|
| |
Susana M. Chuva de Sousa Lopes (The Netherlands)
|
Current status of in vitro differentiation of HPSC into female gametes |
| |
Cristina Eguizabal (Spain)
|
In vitro differentiation of hPSC into male gametes: current status and the road ahead |
| |
Stefan Schlatt (Germany)
|
Stem cell based approaches to restore spermatogenesis in monkeys |
| |
|
|
PCC14: New generation patients
|
| |
Tomas Kucera (Czech Republic)
|
Evolution of socio-demographic situation and reproductive behaviour: do we see the same patient as before? |
| |
Luca Gianaroli (Italy)
|
New applications of PGD |
| |
Ana Cristina Cobo Cabal (Spain)
|
Gametes storage for fertility preservation |
| |
Amparo Ruiz Jorro (Spain)
|
Different models of family thus different types of ART patient |
| |
Karoline Steckley (Italy)
|
E-patients: from Dr. Google to Telemedicine |
| |
Sofia Gameiro (United Kingdom)
|
How to communicate with new generation patients |
|
|